Trend Signal Now: The Hot Corner: Asset Manager Insiders Are Stepping In

Wednesday, February 11, 2026

Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.

📌 Ares Management $ARES — Ashish Bhutani purchased $1.27 million via Form 4.

Buyers showing up near support is exactly what you want to see in a name trying to repair its damage after a sharp drawdown.

📌 Globe Life $GL — Director Mark Blinn bought $153,540 per Form 4.

Smaller in size, but notable insider support as this life insurer presses toward fresh highs.

Here's The Hot Corner, with data from February 10, 2026:

Click the table to enlarge it.

📌 Incyte $INCY — Baker Bros. increased their stake from 15.50% to 15.70%.

One of biotech's most respected specialist investors adding again to a core position. It's incremental, but when long-term operators press their winners, we pay attention.

📌 Ocular Therapeutix $OCUL — Deep Track Capital raised its stake from 4.20% to 5.13%.

Crosses the five percent threshold in a speculative biotech carving out a massive base.

If you want this actionable trade ideas based on insider trading, join Hot Corner Insider risk-free.

The Beat Report is 62% Off

Get 62% off The Beat Report and access Steve Strazza's research, trade ideas, and weekly analysis.

Hurry — this offer expires TOMORROW at midnight ET.

Alfonso De Pablos | Director of Research, All Star Charts

Stock Market Media emails are a financial publication of general circulation and only offers impersonal advice, not tailored to individual needs of a specific client or group. Any comments or statements made herein do not necessarily reflect those of Stock Market Media LLC or its affiliates (collectively, "Stock Market Media") and do not constitute buy or sell recommendations. Unless specifically indicated, this message is not an official confirmation of any transaction. The contents of any email communications to or from Stock Market Media may be monitored or reviewed at Stock Market Media's discretion. Stock Market Media accepts no responsibility for any loss or damage arising in any way from the use of this transmission and any attachments; it is the responsibility of the recipient to ensure that they are virus free. If you reply to this email, please note that we are a public investor and do not want any material non-public information. We do not agree to keep confidential any information you provide and do not agree to any restrictions on our trading activity, except pursuant to a written confidentiality agreement executed by Stock Market Media.

Want to change how you receive these emails? You can manage your preferences here unsubscribe.

© 2026 Stock Market Media 624 Broadway, Suite 405 San Diego, CA 92101